Skip to main content
Premium Trial:

Request an Annual Quote

Yale University, Ingeneus


Yale University has received US Patent Number 6,403,319, “Analysis of sequence tags with hairpin primers,” for rolling circle amplification creator Paul Lizardi’s invention of a method for analyzing nucleic acid samples. In the method, nucleic acid fragments are amplified using a hairpin primer, then coupled to detector probes, and these groups are detected. The method is designed to facilitate quick analysis of a complex nucleic acid sample.


Ingeneus of Bridgetown, Barbados, has received US Patent Number 6,403,313, “Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators.” The invention described is a nucleic acid hybridization assay that can detect specific hybridization between double-stranded target DNA and single-stranded probes, eliminating the need to denature target DNA. The assay can also detect duplexes between single strands. The purpose of the assay is to identify accessible regions of folded nucleotide sequences as well as the number of mismatched pairs in a hybridization complex, and for genome mapping.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.